GSK still in talks about submitting cervical cancer vaccine

01/3/2006 | ABC News

GlaxoSmithKline, seen as trailing rival Merck in getting a cervical cancer vaccine to market, said it still is in talks with the FDA about submitting its drug Cervarix for approval. GSK had been expected to announce a filing timetable before the end of 2005, while Merck's Gardasil already has been submitted to U.S. and European regulators.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD